Association of serum AFP trajectories and hepatocellular carcinoma outcomes after hepatic arterial infusion chemotherapy: A longitudinal, multicenter study

Documenti analoghi

• Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein‐1 inhibitors: A promising treatment approach for high‐burden hepatocellular carcinoma
  di: Shumin Fu, et al.
  Pubblicazione: (2024)
• Impact of inflammation and the immune system on hepatocellular carcinoma recurrence after hepatectomy
  di: Sha She, et al.
  Pubblicazione: (2024)
• Association between novel genetic variants of Notch signaling pathway genes and survival of hepatitis B virus‐related hepatocellular carcinoma
  di: Liming Qin, et al.
  Pubblicazione: (2024)
• A clinical‐radiomic‐pathomic model for prognosis prediction in patients with hepatocellular carcinoma after radical resection
  di: Qu Xie, et al.
  Pubblicazione: (2024)
• Exploring the factors affecting the occurrence of postoperative MVI and the prognosis of hepatocellular carcinoma patients treated with hepatectomy: A multicenter retrospective study
  di: Jilin Yang, et al.
  Pubblicazione: (2024)